PROK1, prognostic marker of embryo implantation?;PROK1, biomarqueur de l'implantation embryonnaire ?

Gynecologie Obstetrique et Fertilite

Volumn 41, Issue 9, 2013, Pages 562-565

  Brouillet, S ^a,b,c   Hoffmann, P ^a,b,c   Thomas Cadi, C ^a   Bergues, U ^a   Feige, J J ^b,c   Alfaidy, N ^b,c   Hennebicq, S ^a,c  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b CEA GRENOBLE   (France)

^c UNIV GRENOBLE ALPES   (France)

Author keywords

Assisted reproductive technology; Biomarker; EG VEGF; Implantation; Prokineticin

Indexed keywords

ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR;

ARTICLE; ASSISTED REPRODUCTIVE TECHNOLOGY; HUMAN; MEDICAL TECHNOLOGY; NIDATION; PREGNANCY OUTCOME;

ASSISTANCE MÉDICALE À LA PROCRÉATION; ASSISTED REPRODUCTIVE TECHNOLOGY; BIOMARKER; BIOMARQUEUR; EG-VEGF; IMPLANTATION; PROKINETICIN; PROKINÉTICINES;

BIOLOGICAL MARKERS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; EMBRYO CULTURE TECHNIQUES; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; HUMANS; OOCYTES; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED;

EID: 84888366372     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2013.07.007     Document Type: Article

References (10)

1. Le Couter J, et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001;412(6850):877-84.
2. Maldonado-Perez D, et al. Potential roles of the prokineticins in reproduction. Trends Endocrinol Metab 2007;18(2):66-72.
3. Gao MZ, et al. Effects of EG-VEGF, VEGF and TGF-beta1 on pregnancy outcome in patients undergoing IVF-ET treatment. J Assist Reprod Genet 2012;29(10): 1091-6.
4. Matsumoto S, et al. Abnormal development of the olfactory bulb and repro-ductive system in mice lacking prokineticin receptor PKR2. Proc Natl Acad Sci USA 2006;103(11):4140-5.
5. Brouillet S, et al. Molecular characterization of EG-VEGF-mediated angiogen-esis: differential effects on microvascular and macrovascular endothelial cells. Mol Biol Cell 2010;21(16):2832-43.
6. Brouillet S, et al. Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors. Cell Mol Life Sci 2012;69(9): 1537-50.
7. Haouzi D, et al. Identification of new biomarkers of human endometrial receptivity in the natural cycle. Hum Reprod 2009;24(1):198-205.
8. Brouillet S, et al. EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR). Cell Mol Life Sci 2013;70(3):511-25.
9. Hoffmann P, et al. Role of EG-VEGF in human placentation: physiological and pathological implications. J Cell Mol Med 2009;13(8B):2224-35.
10. Su MT, et al. Polymorphisms of endocrine gland-derived vascular endothelial growth factor gene and its receptor genes are associated with recurrent pregnancy loss. Hum Reprod 2010;25(11):2923-30.